BeOne Medicines AG (BEIGF)
OTCMKTS · Delayed Price · Currency is USD
24.92
0.00 (0.00%)
At close: Nov 10, 2025
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $39.16 billion as of February 6, 2026. Its market cap has increased by 65.36% in one year.
Market Cap
39.16B
Enterprise Value
36.15B
Revenue
4.97B
Ranking
n/a
PE Ratio
571.32
Stock Price
$24.92
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 858.74M to 39.16B, an increase of 4,460.62%. That is a compound annual growth rate of 46.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 39.16B | 16.49% |
| Dec 31, 2025 | 33.62B | 70.94% |
| Dec 31, 2024 | 19.67B | 4.69% |
| Dec 29, 2023 | 18.79B | -17.76% |
| Dec 30, 2022 | 22.84B | -17.96% |
| Dec 31, 2021 | 27.84B | 18.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 405.51M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |